DOSSIER · UPDATED 18 NOV 2025

Athos Therapeutics

Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

athostx.com ↗Claim this profile

Founded: 2019
Headcount: 21
Open roles: 0
Last raised: Series B · $35M

SECTION I · THE BRIEF

Inside Athos Therapeutics

Brief #50935Updated 18 NOV 2025TORRANCESOFTWARE COMPANIESSERIES B

Employbl Dossier

Athos Therapeutics

Founded: 2019
Headcount: 21
Open roles: 0
Last raised: Series B · $35M

Section II · Premium ProfileMembers only

01Engineering interview process at Athos TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Athos Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Allan J. Pantuck

Founder at Athos Therapeutics

Athos Therapeutics

Michael Jung

Founder at Trethera

TretheraUCLA

DIMITRIOS ILIOPOULOS

CEO at Athos Therapeutics

Athos TherapeuticsDyania HealthMedicusData.AIARISTEiAAttica SciencesBiotechMassachusetts Institute of Technology (MIT)Stanford Graduate School of BusinessUCLA Anderson School of ManagementThe Chinese University of Hong Kong (CUHK) Business School

OPEN ROLES